A detailed history of California Public Employees Retirement System transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 150,520 shares of SRPT stock, worth $16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
150,520
Previous 151,851 0.88%
Holding current value
$16 Million
Previous $24 Million 21.64%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$124.33 - $156.75 $165,483 - $208,634
-1,331 Reduced 0.88%
150,520 $18.8 Million
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $3.18 Million - $4.6 Million
28,066 Added 22.67%
151,851 $24 Million
Q1 2024

Apr 30, 2024

SELL
$93.7 - $141.53 $243,713 - $368,119
-2,601 Reduced 2.06%
123,785 $16 Million
Q4 2023

Feb 01, 2024

SELL
$67.31 - $124.76 $2.56 Million - $4.75 Million
-38,071 Reduced 23.15%
126,386 $12.2 Million
Q3 2023

Nov 02, 2023

SELL
$102.5 - $123.59 $374,022 - $450,979
-3,649 Reduced 2.17%
164,457 $19.9 Million
Q2 2023

Aug 09, 2023

BUY
$106.4 - $157.19 $134,064 - $198,059
1,260 Added 0.76%
168,106 $19.3 Million
Q1 2023

May 12, 2023

SELL
$117.53 - $155.99 $2.98 Million - $3.96 Million
-25,365 Reduced 13.2%
166,846 $23 Million
Q4 2022

Feb 08, 2023

BUY
$100.86 - $132.13 $95,514 - $125,127
947 Added 0.5%
192,211 $24.9 Million
Q3 2022

Nov 09, 2022

BUY
$75.71 - $119.24 $1.72 Million - $2.71 Million
22,766 Added 13.51%
191,264 $21.1 Million
Q2 2022

Aug 10, 2022

SELL
$62.69 - $88.44 $273,014 - $385,156
-4,355 Reduced 2.52%
168,498 $12.6 Million
Q1 2022

May 04, 2022

SELL
$63.15 - $90.42 $332,042 - $475,428
-5,258 Reduced 2.95%
172,853 $13.5 Million
Q4 2021

Feb 10, 2022

BUY
$77.28 - $99.42 $678,827 - $873,305
8,784 Added 5.19%
178,111 $16 Million
Q3 2021

Nov 10, 2021

BUY
$65.97 - $92.48 $998,324 - $1.4 Million
15,133 Added 9.81%
169,327 $15.7 Million
Q2 2021

Aug 13, 2021

SELL
$69.38 - $86.75 $1.04 Million - $1.3 Million
-14,970 Reduced 8.85%
154,194 $12 Million
Q1 2021

May 14, 2021

SELL
$72.25 - $168.95 $909,627 - $2.13 Million
-12,590 Reduced 6.93%
169,164 $12.6 Million
Q4 2020

Feb 02, 2021

BUY
$125.56 - $178.74 $1.35 Million - $1.92 Million
10,735 Added 6.28%
181,754 $31 Million
Q3 2020

Nov 05, 2020

BUY
$127.12 - $172.34 $2.46 Million - $3.33 Million
19,350 Added 12.76%
171,019 $24 Million
Q2 2020

Aug 12, 2020

BUY
$93.0 - $171.7 $648,117 - $1.2 Million
6,969 Added 4.82%
151,669 $24.3 Million
Q1 2020

May 12, 2020

SELL
$82.38 - $131.64 $4.14 Million - $6.62 Million
-50,277 Reduced 25.79%
144,700 $14.2 Million
Q4 2019

Jan 27, 2020

BUY
$76.53 - $135.58 $4.97 Million - $8.8 Million
64,877 Added 49.87%
194,977 $25.2 Million
Q3 2019

Oct 31, 2019

BUY
$72.81 - $156.91 $2.58 Million - $5.55 Million
35,400 Added 37.38%
130,100 $9.8 Million
Q2 2019

Aug 15, 2019

SELL
$112.21 - $151.95 $3 Million - $4.06 Million
-26,720 Reduced 22.01%
94,700 $14.4 Million
Q1 2019

May 03, 2019

SELL
$106.67 - $151.68 $400,652 - $569,710
-3,756 Reduced 3.0%
121,420 $14.5 Million
Q4 2018

Feb 08, 2019

SELL
$97.32 - $148.76 $463,437 - $708,395
-4,762 Reduced 3.66%
125,176 $13.7 Million
Q3 2018

Nov 13, 2018

BUY
$115.31 - $161.51 $312,490 - $437,692
2,710 Added 2.13%
129,938 $21 Million
Q2 2018

Aug 15, 2018

SELL
$71.74 - $153.69 $1.32 Million - $2.82 Million
-18,376 Reduced 12.62%
127,228 $16.8 Million
Q1 2018

May 11, 2018

SELL
$54.02 - $82.27 $59,205 - $90,167
-1,096 Reduced 0.75%
145,604 $10.8 Million
Q4 2017

Feb 06, 2018

BUY
$47.64 - $56.75 $181,032 - $215,650
3,800 Added 2.66%
146,700 $8.16 Million
Q3 2017

Nov 15, 2017

BUY
$35.73 - $47.15 $5.11 Million - $6.74 Million
142,900
142,900 $6.48 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.34B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.